Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

Last updated 8/26/2026, 9:58:28 PM

Cite this record

African DSI DataBank. Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.. AFDSI-PUB-345. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-345 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42602164/.Copy citation

@misc{AFDSIPUB345,
  title        = {Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-345}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-345; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42602164/}
}

AFDSI-PUB-345 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.